Using a hollow microstructured transdermal system to deliver vaccine directly to the dermis.
Dave Cunningham
Advertisement
Dave Cunningham is director, corporate development at Goodwin Biotechnology.
Articles by Dave Cunningham
Advertisement
Latest Updated Articles
Optimizing a Unique Cancer Vaccine for Intradermal DeliveryPublished: September 15th 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
AstraZeneca Next to Agree to MFN Deal: Report
2
How Big Biopharma Investment in CGTs Will Redefine the Industry Pipeline
3
Considerations for Quality Improvement of Cleaning, Disinfection, and Cleaning Validation in Biopharmaceutical Manufacturing, Part II. Biopharmaceutical Non-Sterile Equipment Cleaning
4
BioPharm Weekly News Roundup—Week of Oct. 6, 2025
5
